Graff, S. L., Cardoso, F., Rugo, H. S., Brezden-Masley, C., Werustsky, G., Tripathy, D., O'Shaughnessy, J., Ma, C. X., Danso, M. A., Lu, Y., Başaran, G., Campone, M., Laurentiis, M. D., Cortés, J., Worthy, V., Gao, M., Musel, B., Ye, F., Pantoja, K., Fasching, P. A. (2025). Adjuvant WIDER: A phase 3b trial of ribociclib (RIB) + endocrine therapy (ET) as adjuvant treatment (tx) in a close-to-clinical-practice patient (pt) population with HR+/HER2− early breast cancer (EBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps617